These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17475770)

  • 1. Nitric oxide signaling is disrupted in the yeast model for Batten disease.
    Osório NS; Carvalho A; Almeida AJ; Padilla-Lopez S; Leão C; Laranjinha J; Ludovico P; Pearce DA; Rodrigues F
    Mol Biol Cell; 2007 Jul; 18(7):2755-67. PubMed ID: 17475770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of Btn1p in the yeast model for juvenile Batten disease may cause arginine to become toxic to yeast cells.
    Vitiello SP; Wolfe DM; Pearce DA
    Hum Mol Genet; 2007 May; 16(9):1007-16. PubMed ID: 17341489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease.
    Kim Y; Ramirez-Montealegre D; Pearce DA
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15458-62. PubMed ID: 14660799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of BTN1, the yeast orthologue of the gene mutated in Batten disease.
    Pearce DA; Ferea T; Nosel SA; Das B; Sherman F
    Nat Genet; 1999 May; 22(1):55-8. PubMed ID: 10319861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of Batten disease with the yeast Saccharomyces cerevisiae.
    Pearce DA; Sherman F
    Mol Genet Metab; 1999 Apr; 66(4):314-9. PubMed ID: 10191120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A yeast model for the study of Batten disease.
    Pearce DA; Sherman F
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6915-8. PubMed ID: 9618513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BTN1, the Saccharomyces cerevisiae homolog to the human Batten disease gene, is involved in phospholipid distribution.
    Padilla-López S; Langager D; Chan CH; Pearce DA
    Dis Model Mech; 2012 Mar; 5(2):191-9. PubMed ID: 22107873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic reversal of the btn1 defects in yeast by chloroquine: a yeast model for Batten disease.
    Pearce DA; Carr CJ; Das B; Sherman F
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11341-5. PubMed ID: 10500178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-dependent localization of Btn1p in the yeast model for Batten disease.
    Wolfe DM; Padilla-Lopez S; Vitiello SP; Pearce DA
    Dis Model Mech; 2011 Jan; 4(1):120-5. PubMed ID: 20959629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. btn1, the Schizosaccharomyces pombe homologue of the human Batten disease gene CLN3, regulates vacuole homeostasis.
    Gachet Y; Codlin S; Hyams JS; Mole SE
    J Cell Sci; 2005 Dec; 118(Pt 23):5525-36. PubMed ID: 16291725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The subcellular location of the yeast Saccharomyces cerevisiae homologue of the protein defective in the juvenile form of Batten disease.
    Croopnick JB; Choi HC; Mueller DM
    Biochem Biophys Res Commun; 1998 Sep; 250(2):335-41. PubMed ID: 9753630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Batten disease: evaluation of CLN3 mutations on protein localization and function.
    Haskell RE; Carr CJ; Pearce DA; Bennett MJ; Davidson BL
    Hum Mol Genet; 2000 Mar; 9(5):735-44. PubMed ID: 10749980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of pH regulation by Btn1p, the yeast homolog of human Cln3p.
    Pearce DA; Nosel SA; Sherman F
    Mol Genet Metab; 1999 Apr; 66(4):320-3. PubMed ID: 10191121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective lysosomal arginine transport in juvenile Batten disease.
    Ramirez-Montealegre D; Pearce DA
    Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The yeast model for batten disease: mutations in BTN1, BTN2, and HSP30 alter pH homeostasis.
    Chattopadhyay S; Muzaffar NE; Sherman F; Pearce DA
    J Bacteriol; 2000 Nov; 182(22):6418-23. PubMed ID: 11053386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A disrupted homologue of the human CLN3 or juvenile neuronal ceroid lipofuscinosis gene in Saccharomyces cerevisiae: a model to study Batten disease.
    Guo WX; Mao C; Obeid LM; Boustany RM
    Cell Mol Neurobiol; 1999 Oct; 19(5):671-80. PubMed ID: 10384264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.
    Chan CH; Ramirez-Montealegre D; Pearce DA
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Batten disease gene CLN3 is required for the response to oxidative stress.
    Tuxworth RI; Chen H; Vivancos V; Carvajal N; Huang X; Tear G
    Hum Mol Genet; 2011 May; 20(10):2037-47. PubMed ID: 21372148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.
    Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB
    J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S. pombe btn1, the orthologue of the Batten disease gene CLN3, is required for vacuole protein sorting of Cpy1p and Golgi exit of Vps10p.
    Codlin S; Mole SE
    J Cell Sci; 2009 Apr; 122(Pt 8):1163-73. PubMed ID: 19299465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.